5MG CJC-1295 WITHOUT DAC + 5MG IPAMORELIN KIT (10 VIALS)

CJC-1295 without DAC + Ipamorelin is a research peptide combination involving a growth hormone–releasing hormone (GHRH) analog and a growth hormone secretagogue.

CJC-1295 without DAC has been investigated for its interaction with GHRH receptors and its potential influence on growth hormone signaling, while Ipamorelin has been studied as a selective growth hormone secretagogue that acts through the ghrelin/growth hormone secretagogue receptor (GHS-R).

Because these compounds influence complementary pathways involved in growth hormone release, their combination has attracted research interest in endocrine signaling, growth hormone physiology, protein metabolism, and body-composition–related pathways.

Research in these areas has also examined downstream IGF-1 signaling and the broader physiological effects associated with growth hormone regulation.

The combination remains a subject of research involving endocrine function, metabolic physiology, and growth hormone–related signaling.

Notable Research:
Teichman SL, et al. (2006) — "Prolonged Stimulation of Growth Hormone (GH) and Insulin-Like Growth Factor I Secretion by CJC-1295, a Long-Acting Growth Hormone-Releasing Hormone Analog." Journal of Clinical Endocrinology & Metabolism. 91(3):799-805.
Raun K, et al. (1998) — Research characterizing selective growth hormone secretagogues and their effects on growth hormone release.